MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.pcd.2025.10.008

Медицинская библиотека · Primary care diabetes · 2025

Impact of smart watch mobile application on the risk treatment of type 2 diabetes mellitus (iSMART-DM).

Jang Min Kyoung, Cho Yun Kyung, Moon Jung Yoon, Min Se Hee, Hwang Ju Hee, Jung Chang Hee

СтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

UNLABELLED: Mobile health (mHealth) interventions incorporating smartwatches and personalized coaching show promise in improving diabetes self-management. Although studies report modest glycemic benefits and behavioral improvements from app-based interventions, real-world data from East Asian populations remain limited.

AIMS: To evaluate the effectiveness of a smartwatch-based, app-linked lifestyle intervention (iSMART-DM) in improving glycemic control and self-care behavior in patients with non-insulin-treated type 2 diabetes mellitus (T2DM).

METHODS

In a 12-week, open-label randomized controlled trial, 80 adults with T2DM were randomized in a 2:1 ratio to an intervention group (n = 54; smartwatch + mobile app + structured education) or a control group (n = 26; structured education alone). The primary endpoint was the change in glycated hemoglobin (HbA1c). Secondary endpoints included fasting plasma glucose (FPG), HbA1c target attainment (<6.5 %), and changes in self-care behavior scores using the Summary of Diabetes Self-Care Activities Questionnaire (SDSCA-K). Satisfaction and adherence to the digital health intervention were also assessed.

RESULTS

After 12 weeks, the mean HbA1c change was -0.14 % and -0.13 % in the intervention and control groups, respectively (p = 0.837). No significant differences were observed in FPG change or HbA1c target attainment. However, the intervention group showed significantly greater improvement in SDSCA-K scores (+9.7 points; 95 % CI 4.0-15.6; p = 0.001), particularly in diet and physical activity. User satisfaction with the mobile platform was high, with > 85 % reporting a positive effect on daily health management.

CONCLUSIONS

Although short-term glycemic control showed no significant difference, the smartwatch-based mobile intervention significantly enhanced self-care behaviors in patients with T2DM. These findings highlight the behavioral benefits of wearable-integrated mHealth platforms and support their broader application in lifestyle modification strategies.

Для цитирования: Jang Min Kyoung, Cho Yun Kyung, Moon Jung Yoon, Min Se Hee, Hwang Ju Hee, Jung Chang Hee. Impact of smart watch mobile application on the risk treatment of type 2 diabetes mellitus (iSMART-DM).. Primary care diabetes. 2025. DOI: 10.1016/j.pcd.2025.10.008.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.